Sensitive methods for detecting the presence of cancer associated with the over-expression of galectin-3 using biomarkers derived from galectin-3
US8945511B2 · kind B2 · utility
0Cited by
4References
5Claims
0Family size
Inventors
Key dates
| Filing date | Jun 24, 2010 |
| Grant date | Feb 3, 2015 |
| Priority date | — |
| Expiry date | Sep 27, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P19/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are sensitive methods for determining if a subject has cancer. The methods generally involve quantifying the amount of one or more biomarkers derived from Galectin-3 in a biological sample from the subject by mass spectrometry, wherein an increase in the amount of one or more biomarkers in the biological sample as compared to a control is an indication of the presence of cancer in the subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.